News
- 2017/09/28
- Updated information of CSR
- 2017/08/31
- Nippon Kayaku announces the final data analysis of a global phase 3 study of NK105, a novel macromolecular micelle encapsulating an anticancer drug, will be presented at the ESMO 2017 Congress
- 2017/04/26
- Agreement on major articles of contract for collaboration for CT-P10, in Japan
- 2017/04/11
- Submission of Application for Marketing Approval of CT-P6 Trastuzumab Biosimilar Monoclonal Antibody in Japan